https://orcid.org/0000-0002-9581-1425
References
- Wong CH , SiahKW , LoAW. Estimation of clinical trial success rates and related parameters. Biostatistics20(2), 273–286 (2019).
- Petrova E . Innovation in the pharmaceutical industry: the process of drug discovery and development. In: Innovation and Marketing In: Innovation and Marketing in the Pharmaceutical Industry. International Series in Quantitative Marketing. DingM, EliashbergJ, StremerschS (eds). Springer, NY, USA, 20 (2014).
- Caille S , CuiS , FaulMM , MennenSM , TedrowGS , WalkerSD. Molecular complexity as a driver for chemical process innovation in the pharmaceutical industry. J. Org. Chem.84, 4583–4603 (2019).
- Campos KR , ColemanPJ , AlvarezJCet al. The importance of synthetic chemistry in the pharmaceutical industry. Science363, 1–8 (2020).
- Spring DR . Diversity-oriented synthesis; a challenge for synthetic chemists. Org. Biomol. Chem.22(1), 3867–3870 (2003).
- Schreiber SL . Target-oriented and diversity-oriented organic synthesis in drug discovery. Science287(5460), 1964–1969 (2000).
- Grygorenko OO , VolochnyukDM , RyabukhinSV , JuddDB. The symbiotic relationship between drug discovery and organic chemistry. Chemistry26(6), 1196–1237 (2020).
- Kidd SL , OsbergerTJ , MateuN , SoreHF , SpringDR. Recent applications of diversity-oriented synthesis toward novel, 3-dimensional fragment collections. Front. Chem.6, 1–8 (2018).
- SciFinder. Chemical Abstracts Service, Columbus OH, USA. https://scifinder.cas.org
- Cernak T , DykstraKD , TyagarajanS , VachalP , KrskaSW. The medicinal chemist's toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev.45(3), 546–576 (2016).
- Moira M , DanonJJ , ReekiebTA , KassiouM. An overview of late-stage functionalization in today's drug discovery. Expert Opin. Drug Discov.14(11), 1137–1149 (2019).
- Proctor RSJ , PhippsRJ. Recent advances in Minisci-type reactions. Angew. Chem. Int. Ed. Engl.58, 13666–13699 (2019).
- Borgel J , RitterT. Late-stage functionalization. Chem6, 1877–1887 (2020).
- O'Hara F , BlackmondDG , BaranPS. Radical-based regioselective C-H functionalization of electron-deficient heteroarenes: scope, tunability, and predictability. J. Am. Chem. Soc.135, 12122–12134 (2013).
- Daniels MH , ArmandJR , TanKL. Sequential regioselective C–H functionalization of thiophenes. Org. Lett.18, 3310–3313 (2016).
- Liu P , GaoY , GuW , ShenZ , SunP. Regioselective fluorination of imidazo[1,2-a]pyridines with Selectfluor in aqueous condition. J. Org. Chem.80(22), 11559–11565 (2015).
- Giordanetto F , WållbergA , CasselJet al. Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation. Bioorg. Med. Chem. Lett.22(21), 6665–6670 (2012).
- Hyohdoh I , FuruichiN , AokiTet al. Fluorine scanning by non-selective fluorination: enhancing Raf/MEK inhibition while keeping physicochemical properties. ACS Med. Chem. Lett.4(11), 1059–1063 (2013).
- Actelion Pharmaceuticals . Pyrazole compounds and their use as T-type calcium channel blockers. WO 2015/186056 Al (2015). https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015186056
- Vinogradova EV , MüllerP , BuchwaldSL Structural reevaluation of the electrophilic hypervalent iodine reagent for trifluoromethylthiolation supported by the crystalline sponge method for x-ray analysis. Angew. Chem. Int. Ed. Engl.53, 3125–3128 (2014).